000 01624 a2200433 4500
005 20250516060744.0
264 0 _c20111230
008 201112s 0 0 eng d
022 _a1091-6490
024 7 _a10.1073/pnas.1108945108
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKratky, Wolfgang
245 0 0 _aDirect activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cOct 2011
300 _a17414-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdaptive Immunity
650 0 4 _aAnimals
650 0 4 _aAntigen-Presenting Cells
_xcytology
650 0 4 _aCD8-Positive T-Lymphocytes
_xcytology
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aCell Differentiation
_ximmunology
650 0 4 _aCell Proliferation
650 0 4 _aCell Survival
_ximmunology
650 0 4 _aFemale
650 0 4 _aImmunity, Innate
650 0 4 _aMale
650 0 4 _aMelanoma, Experimental
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aRadiation Chimera
650 0 4 _aT-Lymphocytes, Cytotoxic
_xcytology
700 1 _aReis e Sousa, Caetano
700 1 _aOxenius, Annette
700 1 _aSpörri, Roman
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 108
_gno. 42
_gp. 17414-9
856 4 0 _uhttps://doi.org/10.1073/pnas.1108945108
_zAvailable from publisher's website
999 _c21221432
_d21221432